|234.14||+10.15 / +4.53%|
Data as of 4:00pm ET
|240.00||+5.86 / +2.50%|
The 11 analysts offering 12-month price forecasts for Intercept Pharmaceuticals Inc have a median target of 493.00, with a high estimate of 693.00 and a low estimate of 265.00. The median estimate represents a +110.56% increase from the last price of 234.14.
The current consensus among 11 polled investment analysts is to Buy stock in Intercept Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.